Shares of Hologic (HOLX) are showing impressive gains of late, trading quite near its 52-week high of $84.67. The stock closed Thursday at $80.99, just 4.3% below the highest point. In the past three months, the women's health company's stocks have gained 8.5%, surpassing the industry's growth of 2% and the S&P 500's return of 2.8%. Hologic has also performed better than the industry rivals QIAGEN (QGEN) and Becton, Dickinson and Company (BDX) . Image Source: Zacks Investment Research 3-Months Performance T ...